Cargando…

Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator

The cost of testing can be a substantial contributor to hepatitis C virus (HCV) elimination program costs in many low- and middle-income countries such as Georgia, resulting in the need for innovative and cost-effective strategies for testing. Our objective was to investigate the most cost-effective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adee, Madeline, Zhuo, Yueran, Zhong, Huaiyang, Zhan, Tiannan, Aggarwal, Rakesh, Shilton, Sonjelle, Chhatwal, Jagpreet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560949/ https://www.ncbi.nlm.nih.gov/pubmed/34725356 http://dx.doi.org/10.1038/s41598-021-00362-y

Ejemplares similares

Author Correction: Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator
por: Adee, Madeline, et al.
Publicado: (2022)

Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan
por: Zhuo, Yueran, et al.
Publicado: (2020)

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
por: Chhatwal, Jagpreet, et al.
Publicado: (2019)

Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents
por: Chen, Qiushi, et al.
Publicado: (2020)

Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, India
por: Markby, Jessica, et al.
Publicado: (2021)

Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
por: Aggarwal, Rakesh, et al.
Publicado: (2017)

Cost-effectiveness of Hepatitis C virus self-testing in four settings
por: Walker, Josephine G., et al.
Publicado: (2023)

Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis
por: Sadeghimehr, Maryam, et al.
Publicado: (2021)

Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan
por: Martínez-Pérez, Guillermo Z., et al.
Publicado: (2021)

Assessment and Comparison of Hepatitis C Viremia in the Prison Systems of New Mexico and Georgia
por: Spaulding, Anne C., et al.
Publicado: (2019)

Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income
por: Tordrup, David, et al.
Publicado: (2020)

Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar
por: Win, Thin Mar, et al.
Publicado: (2023)

Home-based hepatitis C self-testing in people who inject drugs and men who have sex with men in Georgia: a protocol for a randomised controlled trial
por: Shilton, Sonjelle, et al.
Publicado: (2022)

Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study
por: Chen, Qiushi, et al.
Publicado: (2019)

Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three‐arm study
por: Shilton, Sonjelle, et al.
Publicado: (2022)

Values and preferences for hepatitis C self-testing among the general population and healthcare workers in Rwanda
por: Serumondo, Janvier, et al.
Publicado: (2021)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Projecting COVID-19 Mortality as States Relax Nonpharmacologic Interventions
por: Linas, Benjamin P., et al.
Publicado: (2022)

Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States
por: Chhatwal, Jagpreet, et al.
Publicado: (2023)

Protocol for a cluster randomised controlled trial of secondary distribution of hepatitis C self-testing within the context of a house-to-house hepatitis C micro-elimination programme in Karachi, Pakistan
por: Shilton, Sonjelle, et al.
Publicado: (2022)

Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugs
por: Hassan, Muhammad Radzi Abu, et al.
Publicado: (2023)

Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits
por: Scott, Nick, et al.
Publicado: (2021)

COVID-19 self-testing, a way to “live side by side with the coronavirus”: Results from a qualitative study in Indonesia
por: Thomas, Catherine, et al.
Publicado: (2022)

Correction: Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugs
por: Hassan, Muhammad Radzi Abu, et al.
Publicado: (2023)

A New Test Paper, Suggested by Private J. C. Wharton, of Atlanta, Georgia
Publicado: (1864)

Improved Health Outcomes from Hepatitis C Treatment Scale-Up in Spain’s Prisons: A Cost-Effectiveness Study
por: Dalgic, Ozden O., et al.
Publicado: (2019)

Assessing Values and Preferences Toward SARS-CoV-2 Self-testing Among the General Population and Their Representatives, Health Care Personnel, and Decision-Makers: Protocol for a Multicountry Mixed Methods Study
por: Shilton, Sonjelle, et al.
Publicado: (2021)

COVID-19 self-testing in Nigeria: Stakeholders’ opinions and perspectives on its value for case detection
por: Undelikwo, Veronica A., et al.
Publicado: (2023)

The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing
por: Tucker, Joseph D., et al.
Publicado: (2017)

Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up
por: Draper, Bridget Louise, et al.
Publicado: (2022)

Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study
por: Draper, Bridget Louise, et al.
Publicado: (2020)

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study
por: Ferrante, Shannon Allen, et al.
Publicado: (2013)

Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary
por: Odhiambo, Raymond, et al.
Publicado: (2013)

Medical Association of Georgia, &c.
Publicado: (1889)

Rapid SARS-CoV-2 Antigen Detection Self-Tests to Increase COVID-19 Case Detection in Peru: Qualitative Study
por: Torres-Slimming, Paola A, et al.
Publicado: (2023)

The feasibility and acceptability of integrating hepatitis C and HIV diagnostic testing on centralized molecular laboratory platforms in Myanmar
por: Naing, Thandar Su, et al.
Publicado: (2023)

Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection
por: Suan, Mohd Azri Mohd, et al.
Publicado: (2022)

Values and preferences of the general population in Indonesia in relation to rapid COVID‐19 antigen self‐tests: A cross‐sectional survey
por: Thomas, Caroline, et al.
Publicado: (2022)

Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
por: Stvilia, Ketevan, et al.
Publicado: (2019)

Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic
por: Chhatwal, Jagpreet, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_854ifdb232dc5dp6kt910l2hpr